Increased β2-microglobulin-free HLA class I heavy chain serum levels in the course of immune responses to viral antigens and to mismatched HLA antigens

Tissue Antigens

Volumn 55, Issue 4, 2000, Pages 333-341

  Puppo, F ^a   Brenci, S ^a   Contini, P ^a   Bignardi, D ^a   Hamby, C V ^b   Filaci, G ^a   Ghio, M ^a   Scudeletti, M ^a   Picciotto, A ^a   Indiveri, F ^a   Ferrone, Soldano ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

2 free HLA class I heavy chains; 2 microglobulin; Soluble HLA antigens

Indexed keywords

ALPHA2B INTERFERON; BETA 2 MICROGLOBULIN; HLA ANTIGEN CLASS 1; RIBAVIRIN; VIRUS ANTIGEN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HLA ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEPATITIS C; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER ISCHEMIA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VIRUS IMMUNITY; BLOOD; BONE MARROW TRANSPLANTATION; FLOW CYTOMETRY; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; ANTI-HIV AGENTS; BETA 2-MICROGLOBULIN; BONE MARROW TRANSPLANTATION; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HLA ANTIGENS; HUMANS; LIVER TRANSPLANTATION; MIDDLE AGED;

EID: 0033625357     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2000.550407.x     Document Type: Article

References (40)

1. 1. Natali PG, Bigotti A, Nicotra MR, Viora M, Manfredi D, Ferrone S. Distribution of human class I (HLA-A,B,C) histocompatibility antigens in normal and malignant tissues of nonlymphoid origin. Cancer Res 1984: 44: 4679-87.
2. 2. Davies H, Pollard SG, Calne RY. Soluble HLA antigens in the circulation of liver graft recipients. Transplantation 1989: 47: 524-7.
3. 3. Westhoff U, Doxiadis I, Beelen DW, Schaefer UW, Grosse-Wilde H. Soluble HLA Class I concentrations and GVHD after allogeneic marrow transplantation. Transplantation 1989: 48: 890-3.
4. 4. Pollard SG, Davies HffS, Calne RY. Peroperative appearance of serum class I antigen during liver transplantation. Transplantation 1990: 49: 659-60.
5. 5. Tilg H, Westhoff U, Vogel W et al. Soluble HLA class I serum concentrations increase with transplant-related complications after liver transplantation. J Hepatol 1992: 14: 417-9.
6. 6. Hagihara M, Shimura T, Yamamoto K et al. Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus. Tokai J Exp Clin Med 1993: 18: 61-4.
7. 7. Rhynes KV, McDonald JC, Gelder FB et al. Soluble HLA Class I in the serum of transplant recipients. Ann Surg 1993: 217: 485-91.
8. 8. Zavazava N, Böttcher H, Müller-Ruchholtz W. Soluble MHC class I antigens (sHLA) and anti-HLA antibodies in heart and kidney allograft recipients. Tissue Antigens 1993: 42: 20-6.
9. 9. DeVito-Haynes LD, Jankowska-Gan E, Sollinger HW, Knechtle SJ, Burlingham WJ. Monitoring of kidney and simultaneous pancreas-kidney transplantation rejection by release of donor-specific, soluble HLA Class I. Hum Immunol 1994: 40: 191-201.
10. 10. Puppo F, Brenci S, Lanza L et al. Increased level of serum HLA Class I antigens in HIV infection. Correlation with disease progression. Hum Immunol 1994: 40: 259-66.
11. 11. Puppo F, Picciotto A, Brenci S et al. Behaviour of soluble HLA class I antigens in patients with chronic hepatitis C during interferon therapy: an early predictor marker of response? J Clin Immunol 1995: 15: 179-84.
12. 12. Puppo F, Brenci S, Ghio M et al. Serum HLA class I antigen levels in allogeneic bone marrow transplantation: a possible marker of acute GVHD. Bone Marrow Transplant 1996: 17: 753-8.
13. 13. Hagihara M, Munkhbat B, Kanai N et al. Serum soluble human leukocyte antigen class I in paediatric liver trarsplantation with live, related donors. Transpl Immunol 1997: 5: 219-24.
14. 14. Liem LM, Koelman CA, Doxiadis I, van Houwelingen JC, Goulmy E, Claas F. Elevated serum HLA class I levels coincide with acute and chronic graft versus host disease. Bone Marrow Transpl 1997: 20: 227-34.
15. 15. Adamashvili I, McVie R, Gelder F et al. Soluble HLA class I antigens in patients with type I diabetes and their family members. Hum Immunol 1997: 55: 176-83.
16. 16. Nocito M, Montalban C, Gonzalez-Porqué P, Villar LM. Increased soluble serum HLA class I antigens in patients with lymphoma. Hum Immunol 1997: 58: 106-11.
17. 17. Bresciani A, Pirozzi G, Spera M et al. Increased level of serum HLA class I antigens in patients with systemic lupus erythematosus. Correlation with disease activity. Tissue Antigens 1998: 52: 44-50.
18. 18. Koelman CA, Mulder A, Jutte NHPM et al. The application of human monoclonal antibodies for monitoring donor derived soluble HLA class I molecules in the serum of heart transplant recipients. Hum Immunol 1998: 59: 106-14.
19. 19. Wolf RE, Adamashvili I, Gelder F, Hall VC, Fraser PA, McDonald J. Soluble HLA-I in rheumatic diseases. Hum Immunol 1998: 59: 644-9.
20. 20. Pickl WF, Majdic O, Faé I, Reuschel R, Holter W, Knapp W. The soluble pool of β2-microglobulin free HLA class I α-chains. J Immunol 1993: 151: 2613-22.
21. 2-μ associated HLA class I heavy chain levels and HLA phenotype. Tissue Antigens 1999: 53: 253-62.
22. 22. CDC 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993: 41: 1-13.
23. 23. D'Urso CM, Wang ZG, Cao Y, Tatake R, Zeff RA, Ferrone S. Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression. J Clin Invest 1991: 87: 284-92.
24. 24. Stam NJ, Spits H, Ploegh HL. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 1986: 137: 2299-306.
25. 25. Pellegrino MA, Ng AK, Russo C, Ferrone S. Heterogeneous distribution of determinants defined by monoclonal antibodies on HLA-A and -B antigens bearing molecules. Transplantation 1982: 34: 18-23.
26. 26. Böyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest 1968: 21 (Suppl 97): 77-89.
27. 27. Russo C, Fotino M, Carbonara A, Ferrone S. A double determinant immunoassay for HLA class I typing using serum as an antigen source. Hum Immunol 1987: 19: 69-77.
28. 28. Comuzio S, Puppo F, Ruzzenenti R et al. Simple ELISA method for the evaluation of soluble HLA class I antigens in human serum. J Lab Clin Anal 1991: 5: 278-83.
29. 29. Demaria S, Schwab R, Bushkin Y. The origin and fate of β2-m-free MHC class I molecules induced on activated T cells. Cell Immunol 1992: 142: 103-13.
30. 30. Neefjes JJ, Smit L, Gehrmann M, Ploegh HL. The fate of the three subunits of major histocompatibility complex class I molecules. Eur J Immunol 1992: 22: 1609-14.
31. 31. Nocera A, Pellicci R, Barocci S et al. HLA antigen expression and cellular infiltrate analysis in rejected and accepted human liver allografts. Clin Transplant 1991: 5: 23-32.
32. 32. Hagihara M, Shimura T, Takebe K et al. Serum concentrations of soluble HLA class I and CD8 forms in patients with viral hepatic disorders. J Gastroenterol 1997: 32: 338-43.
33. 33. Puppo F, Pellicci R, Brenci S et al. HLA class-I-soluble antigen serum levels in liver transplantation. A predictor marker of acute rejection. Hum Immunol 1994: 40: 166-70.
34. 2-microglobulin-free class I heavy chains are released from the surface of activated and leukemia cells by a metalloprotease. J Biol Chem 1994: 269: 6689-94.
35. 35. DeVito-Haynes LD, Demaria S, Bushkin Y, Burlingham WJ. The metalloproteinase-mediated pathway is essential for generation of soluble HLA class I proteins by activated cells in vitro: proposed mechanism for soluble HLA release in transplant rejection. Hum Immunol 1998: 59: 426-34.
36. 36. Dobbe LME, Stam NJ, Neefjes JJ, Giphart MJ. Biochemical complexity of serum HLA class I molecules. Immunogenetics 1988: 27: 203-10.
37. 37. Krangel MS. Secretion of HLA-A and -B antigens via an alternative RNA splicing pathway. J Exp Med 1986: 163: 1173-90.
38. 38. Krangel MS. Two forms of HLA class I molecules in human plasma. Hum Immunol 1987: 20: 155-65.
39. 39. Hauser TA, Malyguine AM, Dawson JR. Conformation dependence of MHC class I in the modulation of target cell sensitivity to natural killing. Hum Immunol 1998: 59: 71-6.
40. 40. Wang ZG, Arienti F, Parmiani G, Ferrone S. Induction and functional characterization of beta2-microglobulin (beta2-mu)-free HLA class I heavy chains expressed by beta2-mu-deficient human FO-1 melanoma cells. Eur J Immunol 1998: 28: 2817-26.